相关实验视频
Updated: Jul 24, 2026
08:58
Murine Kidney Transplant Technique
Published on: October 20, 2015
16.0K
可注射的基因工程水凝,用于促进移植脏的空间耐受性
Jinwen Lin1, Shuaihui Liu1, Xing Xue2
1Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Key Laboratory of Kidney Disease Prevention and Control Technology, National Key Clinical Department of Kidney Diseases, Institute of Nephrology, Zhejiang University, Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, Zhejiang, 310003, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 5, 2024
概括
这项研究引入了一种可注射的水凝 (iGE-Gel),使用工程外细胞囊泡来促进器官移植中的免疫耐受性. 在小鼠模型中,iGE-Gel有效降低了免疫排斥,并延长了生存时间.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
背景情况:
- 在全移植中建立免疫耐受性至关重要,但具有挑战性.
- 细胞因子和接触依赖分子的共同刺激是免疫耐受性的关键.
研究的目的:
- 开发一种可注射的基因工程水凝 (iGE-Gel) 用于促进免疫耐受性.
- 调查iGE-Gel在调节免疫反应和改善移植存活方面的疗效.
主要方法:
- 使用FOXP3工程外细胞囊泡 (Foe-EVs) 和酸改性氨酸 (HASA) 制造iGE-Gel.
- 在体外和体内评估iGE-Gel的自我愈合,可注射性,生物相容性和免疫调节性质.
- 分析免疫细胞透,细胞因子概况,抗体产生,以及在小鼠全基因移植模型中的移植存活率.
主要成果:
- iGE-Gel证明了自我愈合,可注射性和生物相容性.
- iGE-Gel促进了FOXP3+Tregs和PDL1+细胞的耐受性的形成,减少了抗原排水和生殖中心的形成.
- 降低全活性T细胞和B细胞的比例,降低捐赠者特异性抗体 (DSA) 标位,缓解免疫透和损伤,并将接受者的生存时间从30.8天延长到79.3天.
结论:
- iGE-Gel是一种有前途的可注射生物材料,用于诱导全移植中的免疫耐受性.
- 工程水凝有效抑制免疫排斥,并提高移植的生存率.
- 对于器官移植来说,iGE-Gel具有作为一种变革性的治疗策略的潜力.
相关概念视频
00:53Transgenic Organisms
Overview
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...